• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)

21.31 -0.21 (-0.98%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,896,080
Open 21.92
Bid (Size) 21.24 (900)
Ask (Size) 21.90 (100)
Prev. Close 21.52
Today's Range 21.20 - 22.00
52wk Range 10.41 - 129.84
Shares Outstanding 93,148,652
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 31, 2025
From Sarepta Therapeutics, Inc.
Via Business Wire
News headline image
Why Is SRPT Stock Falling Today? ↗
December 11, 2025
Sarepta Therapeutics announced a debt refinancing plan totaling about $291 million. 
Via Stocktwits

Performance

YTD
N/A
N/A
1 Month
-6.6%
-6.6%
3 Month
-8.4%
-8.4%
6 Month
+23.0%
+23.0%
1 Year
-83.1%
-83.1%

More News

Read More
News headline image
Sarepta Therapeutics Announces Refinancing of Approximately $291 Million of 1.25% Convertible Senior Notes due 2027
December 11, 2025
From Sarepta Therapeutics, Inc.
Via Business Wire
News headline image
Dyne Therapeutics (DYN) Navigates a Paradoxical Day: Positive Clinical Data Overshadowed by Dilution Fears
December 09, 2025
Via MarketMinute
News headline image
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
December 03, 2025
Via MarketMinute
News headline image
How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗
December 02, 2025
Via Investor's Business Daily
News headline image
Sarepta Wins FDA Approval To Begin Study On Reducing Liver Injury Risk With Elevidys ↗
November 25, 2025
Via Stocktwits
News headline image
Sarepta Announces Approval to Begin ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne
November 25, 2025
From Sarepta Therapeutics, Inc.
Via Business Wire
News headline image
Sarepta Provides Progress Update for SRP-1003, its Investigational siRNA treatment for Myotonic Dystrophy Type 1
November 24, 2025
From Sarepta Therapeutics, Inc.
Via Business Wire
News headline image
Tech Edges Up Ahead Of Nvidia's Earnings, Bitcoin Sinks Below $90,000: What's Moving Markets Wednesday? ↗
November 19, 2025
Via Benzinga
News headline image
Sarepta Stock Slides Premarket After New FDA Warning Shrinks Market For Its $3.2M DMD Gene Therapy ↗
November 17, 2025
Via Stocktwits
Topics Death
News headline image
2 Beaten-Down Stocks to Avoid Right Now ↗
November 15, 2025
Via The Motley Fool
Topics Death
News headline image
Sarepta Shares Jump After FDA Approves Updated Elevidys Label ↗
November 14, 2025
Via Benzinga
News headline image
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
November 14, 2025
From Sarepta Therapeutics, Inc.
Via Business Wire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
November 11, 2025
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
November 05, 2025
Via Benzinga
News headline image
Analyst Ratings Send Ripples Through Markets: Sarepta's Resilience vs. Pinterest's Plunge
November 05, 2025
Via MarketMinute
News headline image
This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗
November 05, 2025
Via Benzinga
News headline image
Sarepta Therapeutics Shares Plummet as Key DMD Treatments Miss Primary Endpoint in Late-Stage Trial
November 04, 2025
Via MarketMinute
Topics Death
News headline image
Which stocks are experiencing notable movement on Tuesday? ↗
November 04, 2025
Via Chartmill
News headline image
Gold Falls Over 1%; Uber Shares Decline After Q3 Results ↗
November 04, 2025
Via Benzinga
News headline image
Sarepta Faces Investor Skepticism As Duchenne Data Falls Short Of Statistical Significance ↗
November 04, 2025
Via Benzinga
News headline image
Tuesday's session: top gainers and losers ↗
November 04, 2025
Via Chartmill
News headline image
Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It ↗
November 04, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
November 04, 2025
Via Benzinga

Frequently Asked Questions

Is Sarepta Therapeutics, Inc. - Common Stock publicly traded?
Yes, Sarepta Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Sarepta Therapeutics, Inc. - Common Stock trade on?
Sarepta Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sarepta Therapeutics, Inc. - Common Stock?
The ticker symbol for Sarepta Therapeutics, Inc. - Common Stock is SRPT on the Nasdaq Stock Market
What is the current price of Sarepta Therapeutics, Inc. - Common Stock?
The current price of Sarepta Therapeutics, Inc. - Common Stock is 21.31
When was Sarepta Therapeutics, Inc. - Common Stock last traded?
The last trade of Sarepta Therapeutics, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Sarepta Therapeutics, Inc. - Common Stock?
The market capitalization of Sarepta Therapeutics, Inc. - Common Stock is 1.98B
How many shares of Sarepta Therapeutics, Inc. - Common Stock are outstanding?
Sarepta Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap